Jpmorgan Chase & Co

13F Holdings History for Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI)

Symbol: ITCI
Investment type: Equity / Common Stock, $0.0001 Par Value Per Share
Latest Disclosed Ownership: 0 shares
Security Ownership: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

JPMORGAN CHASE & CO. ownership in Intra-Cellular Therapies, Inc. Common Stock, $0.0001 Par Value Per Share (ITCI)

2025-06-05 - JPMORGAN CHASE & CO. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Intra-Cellular Therapies, Inc. Common Stock, $0.0001 Par Value Per Share (ITCI). This represents 0% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
JPMORGAN CHASE & CO.	0%			0			$131.87	13G/A	5/30/2025	5 Jun 2025 13:42:44

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025		-0.01%	$0	0	-759,991	-100%		Q2 2025
3/31/2025	0.01%	-0.04%	$100M	760K	-4,366,101		$131.92	Q1 2025
12/31/2024	0.03%	0%	$428M	5.13M	-160,193	-3.03%	$83.52	Q4 2024
9/30/2024	0.03%	+0.01%	$387M	5.29M	+1,851,053	+53.9%	$73.17	Q3 2024
6/30/2024	0.02%	+0.01%	$235M	3.44M	+1,679,284	+95.6%	$68.49	Q2 2024
3/31/2024	0.01%	0%	$122M	1.76M	-316,667	-15.3%	$69.20	Q1 2024
12/31/2023	0.02%	+0%	$148M	2.07M	+8,813	+0.43%	$71.62	Q4 2023
9/30/2023	0.01%	+0%	$108M	2.06M	+86,388	+4.37%	$52.09	Q3 2023
6/30/2023	0.01%	+0%	$125M	1.98M	+146,530	+8%	$63.32	Q2 2023
3/31/2023	0.01%	+0%	$99.1M	1.83M	+332,970	+22.2%	$54.15	Q1 2023
12/31/2022	0.01%	+0.01%	$79.3M	1.5M	+1,310,130	+698%	$52.92	Q4 2022
9/30/2022	0%	0%	$8.74M	188K	-1,433	-0.76%	$46.53	Q3 2022
6/30/2022	0%	+0%	$10.8M	189K	+32,073	+20.4%	$57.08	Q2 2022
3/31/2022	0%	+0%	$9.62M	157K	+16,454	+11.7%	$61.19	Q1 2022
12/31/2021	0%	0%	$7.36M	141K	-1,313	-0.92%	$52.34	Q4 2021
9/30/2021	0%	0%	$5.29M	142K	-2,091	-1.45%	$37.27	Q3 2021
6/30/2021	0%	0%	$5.88M	144K	-5,309	-3.55%	$40.81	Q2 2021
3/31/2021	0%	0%	$5.07M	149K	-10,200	-6.39%	$33.94	Q1 2021
12/31/2020	0%	0%	$5.08M	160K	-3,940	-2.41%	$31.80	Q4 2020
9/30/2020	0%	0%	$4.18M	164K	-2,719	-1.64%	$25.54	Q3 2020
6/30/2020	0%	+0%	$4.27M	166K	+2,261	+1.38%	$25.67	Q2 2020
3/31/2020	0%	0%	$2.52M	164K	-215,318	-56.8%	$15.37	Q1 2020
12/31/2019	0%	+0%	$13M	379K	+164,495	+76.6%	$34.31	Q4 2019
9/30/2019	0%	+0%	$1.6M	215K	+4,293	+2.04%	$7.47	Q3 2019
6/30/2019	0%	0%	$2.68M	211K	-7,045	-3.24%	$12.71	Q2 2019
3/31/2019	0%	0%	$2.65M	218K	-31,824	-12.8%	$12.18	Q1 2019
12/31/2018	0%	+0%	$2.84M	249K	+32,168	+14.8%	$11.39	Q4 2018
9/30/2018	0%	0%	$4.71M	217K	-39,263	-15.3%	$21.70	Q3 2018
6/30/2018	0%	0%	$4.53M	256K	-127,275	-33.2%	$17.67	Q2 2018
3/31/2018	0%	0%	$8.08M	384K	-133,537	-25.8%	$21.05	Q1 2018
12/31/2017	0%	+0%	$7.49M	517K	+108,882	+26.7%	$14.48	Q4 2017
9/30/2017	0%	+0%	$6.31M	408K	+408,425	NEW	$15.45	Q3 2017
6/30/2017		0%	$0	0	-53,915	-100%		Q2 2017
3/31/2017	0%	0%	$876K	53.9K	-41,624	-43.6%	$16.25	Q1 2017
12/31/2016	0%	+0%	$1.44M	95.5K	+93,339	+4243%	$15.08	Q4 2016
9/30/2016	0%	0%	$34K	2.2K	-144,076	-98.5%	$15.45	Q3 2016
6/30/2016	0%	+0%	$5.68M	146K	+99,051	+210%	$38.82	Q2 2016
3/31/2016	0%	+0%	$1.31M	47.2K	+11,097	+30.7%	$27.80	Q1 2016
12/31/2015	0%	+0%	$1.94M	36.1K	+36,128	NEW	$53.78	Q4 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.